Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for cancer: future potential.

J Cuzick1

  • 1Department of Mathematics, Statistics and Epidemiology, Imperial Cancer Research Fund, London, U.K. j.cuzick@icrf.icnet.uk

European Journal of Cancer (Oxford, England : 1990)
|March 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.

Clinical oncology (Royal College of Radiologists (Great Britain))·2015
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Advancing cancer screening is crucial for reducing global cancer deaths. Innovations in cervical, breast, and colorectal cancer screening show promise, but new strategies are needed for widespread impact.

Area of Science:

  • Oncology
  • Public Health
  • Preventive Medicine

Background:

  • Significant advancements in cancer screening have occurred, yet substantial progress is still required to decrease global cancer mortality.
  • Current screening methods face challenges related to cost, infrastructure, and accessibility, particularly in developing nations.

Purpose of the Study:

  • To review the current state and future potential of cancer screening strategies for major cancers.
  • To identify areas where new approaches are needed to improve effectiveness and accessibility worldwide.

Main Methods:

  • Review of existing literature and current practices in cancer screening.
  • Analysis of the impact and limitations of established screening modalities.
  • Exploration of emerging technologies and novel approaches for cancer detection.

Related Experiment Videos

Main Results:

  • Cytological screening for cervical cancer precursors has significantly reduced mortality but is resource-intensive.
  • Breast screening demonstrates mortality benefits for women over 50, with ongoing needs for improved strategies.
  • Colorectal cancer screening presents a strong opportunity for substantial mortality reduction in the near future.
  • Screening for lung, prostate, and ovarian cancers remains less certain, necessitating further research and development.

Conclusions:

  • While progress has been made, innovative and cost-effective screening methods, such as human papillomavirus testing and automated liquid-based cytology, are essential for global cancer control.
  • Addressing the challenges in breast and other cancer screenings requires radical new approaches to achieve greater impact.
  • Colorectal cancer screening holds significant promise for reducing mortality, and continued investigation into other major cancers is warranted.